日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Antitumor activity of rucaparib plus PLX038A in serous endometrial carcinoma.

rucaparib 联合 PLX038A 治疗浆液性子宫内膜癌的抗肿瘤活性

Hou Xiaonan, Zanfagnin Valentina, Xu Conway, Jessen Erik, Liu Yuanhang, Wang Chen, Huang Yajue, Fontaine Shaun D, Santi Daniel V, Colon-Otero Gerardo, Gill Sarah E, Glaser Gretchen E, Butler Kristina A, Bakkum-Gamez Jamie N, Dowdy Sean C, Oberg Ann L, Larson Melissa C, Atkinson Hunter J, Duffield Laura N, Peterson Kevin L, Kaufmann Scott H, Weroha S John

Clinical Treatment Score Post-5 Years (CTS5) and Late Recurrence Risk in Hormone Receptor-Positive, HER2-Positive Breast Cancer

临床治疗评分5年后(CTS5)与激素受体阳性、HER2阳性乳腺癌的晚期复发风险

Chumsri, Saranya; Pai, Tanmayi; Ma, Yaohua; Li, Zhuo; Gil, Angelica; Moreno-Aspitia, Alvaro; Colon-Otero, Gerardo; Pogue-Geile, Katherine L; Rasgoti, Priya; Paik, Soonmyung; Perez, Edith A; Thompson, E Aubrey

Safety of nab-paclitaxel following an allergic reaction to paclitaxel: A single institution retrospective study

对紫杉醇过敏反应后使用纳米白蛋白紫杉醇的安全性:一项单中心回顾性研究

Kochuveettil, Swapna; Angeli Morales, Roberto; Kaminska, Alicja; Colon-Otero, Gerardo

Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial

在辅助性 NSABP B-31 临床试验中重复验证化疗相关心脏毒性的遗传关联

Advani, Pooja P; Ruddy, Kathryn J; Herrmann, Joerg; Ray, Jordan C; Craver, Emily C; Yothers, Greg; Cecchini, Reena S; Lipchik, Corey; Feng, Huichen; Rastogi, Priya; Mamounas, Eleftherios P; Swain, Sandra M; Geyer, Charles E Jr; Wolmark, Norman; Paik, Soonmyung; Pogue-Geile, Katherine L; Colon-Otero, Gerardo; Perez, Edith A; Norton, Nadine

Efficacy of gemcitabine in combination with nanoparticle albumin-bound paclitaxel in the treatment of recurrent ovarian cancer: A retrospective single institution review

吉西他滨联合纳米白蛋白结合型紫杉醇治疗复发性卵巢癌的疗效:一项回顾性单中心研究

Kase, Adam M; Azzouqa, Abdel-Ghani; Kochuveettil, Swapna; Colon-Otero, Gerardo

Trends in participant race and sex reporting in lung cancer phase III clinical trials

肺癌 III 期临床试验中参与者种族和性别报告的趋势

Aslam, Faaiq N; Manochakian, Rami; Lou, Yanyan; Colon-Otero, Gerardo; Sher, Taimur

Adaptive immune signature in HER2-positive breast cancer in NCCTG (Alliance) N9831 and NeoALTTO trials

NCCTG(Alliance)N9831 和 NeoALTTO 试验中 HER2 阳性乳腺癌的适应性免疫特征

Chumsri, Saranya; Li, Zhuo; Serie, Daniel J; Norton, Nadine; Mashadi-Hossein, Afshin; Tenner, Kathleen; Brauer, Heather Ann; Warren, Sarah; Danaher, Patrick; Colon-Otero, Gerardo; Partridge, Ann H; Carey, Lisa A; Hilbers, Florentine; Van Dooren, Veerle; Holmes, Eileen; Di Cosimo, Serena; Werner, Olena; Huober, Jens Bodo; Dueck, Amylou C; Sotiriou, Christos; Saura, Cristina; Moreno-Aspitia, Alvaro; Knutson, Keith L; Perez, Edith A; Thompson, E Aubrey

Complete response to pembrolizumab in a patient with dermatomyositis and MMR deficient ovarian cancer: A case report

一例皮肌炎合并错配修复缺陷型卵巢癌患者对帕博利珠单抗治疗完全缓解的病例报告

Valls, Maia L; Kase, Adam M; Patel, Rina; Wang, Benjamin; Aggarwal, Rohit; Colon-Otero, Gerardo

Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers

利博西尼联合来曲唑治疗复发性雌激素受体阳性卵巢癌或子宫内膜癌患者的II期试验

Colon-Otero, Gerardo; Zanfagnin, Valentina; Hou, Xiaonan; Foster, Nathan R; Asmus, Erik J; Wahner Hendrickson, Andrea; Jatoi, Aminah; Block, Matthew S; Langstraat, Carrie L; Glaser, Gretchen E; Dinh, Tri A; Robertson, Matthew W; Camoriano, John K; Butler, Kristina A; Copland, John A; Weroha, S John

Intra-CSF topotecan in treatment of breast cancer patients with leptomeningeal metastases

脑脊液内注射拓扑替康治疗伴有软脑膜转移的乳腺癌患者

Jaeckle, Kurt A; Dixon, Jesse G; Anderson, Stephen Keith; Moreno-Aspitia, Alvaro; Colon-Otero, Gerardo; Hebenstreit, Kathy; Patel, Tejal A; Reddy, Samarth L; Perez, Edith A